{
    "2021-05-01": [
        [
            {
                "time": "2022-11-15",
                "original_text": "The Pfizer CEO Prediction That Could Mean Total COVID Market Dominance in 2022",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "CEO",
                        "Prediction",
                        "COVID",
                        "Market Dominance",
                        "2022"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-11-15",
                "original_text": "Don't Race Out To Buy Pfizer Inc. (NYSE:PFE) Just Because It's Going Ex-Dividend",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Ex-Dividend",
                        "Buy",
                        "Race Out"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}